This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Sapporo Breweries Limited. Active years: 1992-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992-2008
Title: The Innovative Contributions of Saburo Sone
Introduction
Saburo Sone is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of biomedical research, particularly in understanding bone metastasis in cancer patients. With a total of 3 patents to his name, Sone's work has the potential to impact therapeutic strategies for lung cancer patients.
Latest Patents
Sone's latest patents focus on the development of non-human animal models that exhibit bone metastasis of tumor cells. The first patent provides a model animal in which tumor cells capable of inducing bone metastasis through peripheral administration have been introduced. This model is crucial for understanding the biology of bone metastasis and developing novel therapeutic strategies for lung cancer patients with multi-organ metastases, including bone metastasis. The second patent also centers on a non-human bone metastasis model animal and introduces a method for screening agents that inhibit or prevent bone metastasis of tumor cells. This innovative approach may lead to significant advancements in cancer treatment.
Career Highlights
Throughout his career, Saburo Sone has worked with prominent companies such as Chugai Seiyaku Kabushiki Kaisha and Sapporo Breweries Limited. His experience in these organizations has contributed to his expertise in the field of biomedical research.
Collaborations
Sone has collaborated with notable colleagues, including Toyokazu Miki and Masanobu Munekata. These partnerships have likely enriched his research and innovation efforts.
Conclusion
Saburo Sone's contributions to the understanding of bone metastasis and his innovative patents highlight his importance in the field of biomedical research. His work has the potential to lead to significant advancements in cancer treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

